UPM presents portfolio strategy to accelerate growth and improve margins
Bitget2026/10/29 11:29- UPM expects second-half 2026 comparable EBIT from continuing operations of €375 million–€575 million, excluding discontinued plywood operations.
- Third-quarter comparable EBIT from continuing operations fell 8% to €131 million as customer destocking reduced deliveries and variable costs increased.
- Operating cash flow rose to €420 million from €218 million a year earlier, supported by improved working capital efficiency.
- The European Commission reiterated serious concerns about the planned Sappi graphic paper joint venture; discussions cover specific remedies, excluding divestments.
- Leuna’s integrated biochemicals production is expected to start in second-quarter 2027, with nominal capacity targeted for early 2028.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.
